Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer

Por Berghmans, Thierry, Remmelink, Myriam, Awada, Ahmad
Publicado no Lung Cancer (Auckl) (2012)

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature

Por Amzerin, Mounia, Garcia, Camilo, Stanciu, Claudia, Veys, Isabelle, Awada, Ahmad, Errihani, Hassan, Gombos, Andrea
Publicado no F1000Res (2014)

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

Por Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad
Publicado no Breast Cancer Res Treat (2014)

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

Por Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad
Publicado no Breast Cancer Res Treat (2015)

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer

Por SIDERIS, SPYRIDON, AOUN, FOUAD, ZANATY, MARC, MARTINEZ, NIEVES CHANZA, LATIFYAN, SOFIA, AWADA, AHMAD, GIL, THIERRY
Publicado no Mol Clin Oncol (2016)

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer

Por Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.
Publicado no Breast Cancer (Auckl) (2016)

Cancer immunotherapy: from the lab to clinical applications—Potential impact on cancer centres’ organisation

Por Cairns, Linda, Aspeslagh, Sandrine, Anichini, Andrea, Kyte, Jon Amund, Blank, Christian, Ascierto, Paolo, Rekers, Nicolle, Straten, Per Thor, Awada, Ahmad
Publicado no Ecancermedicalscience (2016)

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors

Por Gil, Thierry, Sideris, Spyridon, Aoun, Fouad, van Velthoven, Roland, Sirtaine, Nicolas, Paesmans, Marianne, Ameye, Lieveke, Awada, Ahmad, Devriendt, Daniel, Peltier, Alexandre
Publicado no Mol Clin Oncol (2016)

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracyclin...

Por Kaufman, Peter A., Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A., Velikova, Galina, Olivo, Martin S., He, Yi, Dutcus, Corina E., Cortes, Javier
Publicado no J Clin Oncol (2015)

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 tria...

Por Cortes, Javier, Hudgens, Stacie, Twelves, Chris, Perez, Edith A., Awada, Ahmad, Yelle, Louise, McCutcheon, Susan, Kaufman, Peter A., Forsythe, Anna, Velikova, Galina
Publicado no Breast Cancer Res Treat (2015)

“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy

Por Twelves, Christopher, Cortes, Javier, Kaufman, Peter A., Yelle, Louise, Awada, Ahmad, Binder, Terri A., Olivo, Martin, Song, James, O’Shaughnessy, Joyce A., Jove, Maria, Perez, Edith A.
Publicado no Breast Cancer Res (2015)

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Por Tolaney, Sara M., Nechushtan, Hovav, Ron, Ilan-Gil, Schöffski, Patrick, Awada, Ahmad, Yasenchak, Chris A., Laird, A. Douglas, O’Keeffe, Bridget, Shapiro, Geoffrey I., Winer, Eric P.
Publicado no Breast Cancer Res Treat (2016)

Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity

Por Awada, Ahmad, Dumez, Herlinde, Aftimos, Philippe G., Costermans, Jo, Bartholomeus, Sylvie, Forceville, Kathleen, Berghmans, Thierry, Meeus, Marie-Anne, Cescutti, Jessica, Munzert, Gerd, Pilz, Korinna, Liu, Dan, Schöffski, Patrick
Publicado no Invest New Drugs (2015)

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer...

Por Gerlier, Laetitia, Lamotte, Mark, Awada, Ahmad, Bosly, André, Bries, Greet, Cocquyt, Véronique, Focan, Christian, Henry, Stéphanie, Lalami, Yassine, Machiels, Jean-Pascal, Mebis, Jeroen, Straetmans, Nicole, Verhoeven, Didier, Somers, Luc
Publicado em 2010

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patie...

Por Deleporte, Amelie, Paesmans, Marianne, Garcia, Camilo, Vandeputte, Caroline, Lemort, Marc, Engelholm, Jean-Luc, Hoerner, Frederic, Aftimos, Philippe, Awada, Ahmad, Charette, Nicolas, Machiels, Godelieve, Piccart, Martine, Flamen, Patrick, Hendlisz, Alain
Publicado em 2014

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial

Por Cortés, Javier, Rugo, Hope S., Twelves, Chris, Awada, Ahmad, Perez, Edith A., Im, Seock-Ah, Zhao, Carol, Hoch, Ute, Tomkinson, Denise, Buchanan, James, Tagliaferri, Mary, Hannah, Alison, O’Shaughnessy, Joyce
Publicado no Springerplus (2016)

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

Por Locatelli, Marzia A., Aftimos, Philippe, Dees, E. Claire, LoRusso, Patricia M., Pegram, Mark D., Awada, Ahmad, Huang, Bo, Cesari, Rossano, Jiang, Yuqiu, Shaik, M. Naveed, Kern, Kenneth A., Curigliano, Giuseppe
Publicado no Oncotarget (2016)

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer

Por Agarwal, Neeraj, Machiels, Jean-Pascal, Suárez, Cristina, Lewis, Nancy, Higgins, Michaela, Wisinski, Kari, Awada, Ahmad, Maur, Michela, Stein, Mark, Hwang, Andy, Mosher, Rebecca, Wasserman, Ernesto, Wu, Gang, Zhang, Hefei, Zieba, Renata, Elmeliegy, Mohamed
Publicado no Oncologist (2016)

NT-23 PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)

Por Kerklaan, Bojana Milojkovic, Jager, Agnes, Aftimos, Philippe, Dieras, Veronique, Altintas, Sevilay, Anders, Carey, Arnedos, Monica, Gelderblom, Hans, Soetekouw, Patricia, Gladdines, Werner, Gaillard, Pieter, de Sousa, Carlos, Awada, Ahmad, Schellens, Jan, van Linde, Myra, Brandsma, Dieta
Publicado em 2014

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

Por Hendlisz, Alain, Golfinopoulos, Vassilis, Deleporte, Amelie, Paesmans, Marianne, Mansy, Hazem El, Garcia, Camilo, Peeters, Marc, Annemans, Lieven, Vandeputte, Caroline, Maetens, Marion, Borbath, Ivan, Dresse, Damien, Houbiers, Ghislain, Fried, Michael, Awada, Ahmad, Piccart, Martine, Laethem, Jean-Luc Van, Flamen, Patrick
Publicado em 2013